HBV Suppression by Nucleos(t)ide Analogues Reduces PD ‐1 Expression on Liver‐Resident T Cells
Liver International · 2025
DOI: 10.1111/liv.70338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Mireia García-López und 17 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit, Hospital Clínic, University of Barcelona, IDIBAPS, CIBEREHD, Barcelona, Spain. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, Hepatitis B, Chronic, Hepatitis B virus, Antiviral Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Instituto de Salud Carlos III, European Commission.
Abstract (Originalsprache)
Background and Aim PD‐1‐expressing T cells within the HBV‐infected liver constitute a target of novel immunotherapeutics. Our aim was to investigate the impact of viral suppression on PD‐1 expression on intrahepatic versus circulating lymphocyte populations from chronic hepatitis B (CHB) patients.
Methods
Twenty‐two CHB patients, nine of them on nucleos(t)ide analogues (NUCs), had paired blood, liver fine needle aspirations (FNAs) and biopsies. A subset had a follow‐up FNA after treatment initiation ( n = 4) or discontinuation ( n = 4). Intrahepatic (iHBV‐DNA and cccDNA) and serum (HBV‐DNA, HBsAg, HBcrAg and cirB‐RNA) viral markers were quantified. Flow cytometry was used for immunophenotyping PBMCs and intrahepatic lymphocytes. An independent liver FNA scRNAseq dataset was used to consolidate our results.
Results
PD‐1 expression on tissue‐resident memory CD8 T cells (T RM ) correlated with both iHBV‐DNA and cccDNA, as well as surrogate markers of cccDNA transcriptional activity (cirB‐RNA and HBcrAg) in CHB patients with mild hepatitis. These associations were not reflected in circulating T cells. PD‐1 expression intensity on CD8 T RM was lower in NUC‐treated than in naive patients, changes that were again not detectable in the circulation. Longitudinal analysis showed that viral load rebound induced by NUC discontinuation had the potential to drive re‐expression of high levels of PD‐1 on CD8 T RM . Conversely, therapy initiation and subsequent viral suppression reversed these changes. scRNAseq results further extended the profiling of these PD‐1 + CD8 T RM , showing a phenotype consistent with bystander activation in response to subclinical liver damage.
Conclusions
Intrahepatic viral markers correlate with PD‐1 expression on global liver‐resident T cells of CHB patients with mild hepatitis, with a reduction after prolonged NUC therapy and re‐expression following treatment withdrawal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liver Unit, Hospital Clínic, University of Barcelona, IDIBAPS, CIBEREHD, Barcelona, Spain.
- Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, London, UK.
- Radiology Department, Centro de Diagnóstico Por la Imagen (CDI), Hospital Clínic, University of Barcelona, Barcelona, Spain.
- Liver Pathology Unit, Department of Biochemistry and Microbiology, Hospital Universitari Vall D'hebron, Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain.
- Toronto Centre for Liver Disease, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Mireia García-López, Sabela Lens, Laura J Pallett, Anna Pocurull, Thais Leonel, Ernest Belmonte, Ester García-Pras, Sergio Rodríguez-Tajes, Zoe Mariño, Maria Sàez-Palma, Ariadna Rando-Segura, Francisco Rodríguez-Frías, Adam J Gehring, Mala K Maini, Xavier Forns, Sofía Pérez-Del-Pulgar
Förderung
- Wellcome Trust
- Instituto de Salud Carlos III
- European Commission
- Societat Catalana de Digestologia
- Generalitat de Catalunya
- Asociación Española para el Estudio del Hígado
Zitieren
APA
García-López, M., Lens, S., Pallett, L. J., Pocurull, A., Leonel, T., Belmonte, E., García-Pras, E., Rodríguez-Tajes, S., Mariño, Z., Sàez-Palma, M., Bartres, C., Rando-Segura, A., Rodríguez-Frías, F., Lin, J., Gehring, A. J., Maini, M. K., Forns, X., & Pérez-Del-Pulgar, S. (2025). HBV Suppression by Nucleos(t)ide Analogues Reduces PD ‐1 Expression on Liver‐Resident T Cells. Liver International. https://doi.org/10.1111/liv.70338
Vancouver
García-López M, Lens S, Pallett LJ, Pocurull A, Leonel T, Belmonte E, et al. HBV Suppression by Nucleos(t)ide Analogues Reduces PD ‐1 Expression on Liver‐Resident T Cells. Liver International. 2025. doi:10.1111/liv.70338
BibTeX
@article{GarcaLpez2025,
author = {García-López, Mireia and Lens, Sabela and Pallett, Laura J and Pocurull, Anna and Leonel, Thais and Belmonte, Ernest and García-Pras, Ester and Rodríguez-Tajes, Sergio and Mariño, Zoe and Sàez-Palma, Maria and Bartres, Concepción and Rando-Segura, Ariadna and Rodríguez-Frías, Francisco and Lin, Jonah and Gehring, Adam J and Maini, Mala K and Forns, Xavier and Pérez-Del-Pulgar, Sofía},
title = {HBV Suppression by Nucleos(t)ide Analogues Reduces PD ‐1 Expression on Liver‐Resident T Cells},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70338}
}
EUVIMED